Paul Mulholland
University College Hospital(GB)Royal London Hospital(GB)Cancer Research UK(GB)CRUK Lung Cancer Centre of Excellence(GB)University College London(GB)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Radiomics and Machine Learning in Medical Imaging, Cancer Immunotherapy and Biomarkers, MRI in cancer diagnosis
Most-Cited Works
- → Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma(2020)1,394 cited
- → Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma(2013)590 cited
- → First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma(2018)531 cited
- → Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial(2022)451 cited
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)373 cited
- → Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic Tumors